Illumina | ILMN - Operating Profit


Illumina reported $239M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Agilent USD 399M 46M Mar/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 53.9M 10M Dec/2025
Boston Scientific USD 1.05B 190M Mar/2026
Bruker USD 10.2M 66.1M Mar/2026
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 32M 506M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Illumina USD 239M 17M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Laboratory Of America USD 410.1M 28.1M Mar/2026
Mettler Toledo International USD 233.93M 118M Mar/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Quidel USD -31.8M 5.5M Mar/2026
Repligen USD 19.98M 13K Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Standard Biotools USD -21.92M 1.55M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Waters USD 148M 122.52M Mar/2026